{'fraction_non_alphanumeric': 0.014840182648401826, 'fraction_numerical': 0.0, 'mean_word_length': 4.965986394557823, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Biotech Venture Capital

There are only a few dozen top life science venture capital (VC) funds yet no formal study to our knowledge has evaluated what differentiates the firms or investing styles. We attempt to explain how the top life science venture capital investors evaluate investing opportunities in private biotechnology companies. While this article does not attempt to teach the proper way to invest, since clearly there are as many different styles as there are venture firms, the authors hope to shed some light on how some of the best biotechnology investors approach companies and investment decisions. The results suggest that there is a link between a style of investing and the people's backgrounds at these firms. Furthermore, there is some loose correlation to the investing style to the returns enjoyed. Lastly, a few myths about the industry are debunked.